A Study of LY3437943 in Participants With Type 2 Diabetes
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Eli Lilly and Company
Related studies linked through entity extraction aliases.
A Study of A Novel Approach to Titrate Basal Insulin (LY2963016) in Participants With Type 2 Diabetes
- Status
- WITHDRAWN
- Phase
- PHASE4
A Study of LOXO-305 in Chinese Participants With Blood Cancer (Including Lymphoma and Chronic Leukemia)
- Status
- COMPLETED
- Phase
- PHASE2
A Device Study in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Tirzepatide (LY3298176) in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF) and Obesity: The SUMMIT Trial
- Status
- COMPLETED
- Phase
- PHASE3
A Study of Tirzepatide (LY3298176) in Participants With Obesity Disease
- Status
- COMPLETED
- Phase
- PHASE3
A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
- Status
- RECRUITING
- Phase
- PHASE3
A Study of LY3461767 in Participants With Chronic Heart Failure With Reduced Ejection Fraction
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Lebrikizumab (LY3650150) Administered by Two Different Devices in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
A Study of LY3484356 in Healthy Female Participants
- Status
- COMPLETED
- Phase
- PHASE1
A Study of LY3437943 in Japanese Participants With Type 2 Diabetes Mellitus (T2DM)
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Selpercatinib After Surgery or Radiation in Participants With Non-Small Cell Lung Cancer (NSCLC)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Study of Two Doses of Dulaglutide (LY2189265) in Japanese Patients With Type 2 Diabetes
- Status
- COMPLETED
- Phase
- PHASE3
A Drug Drug Interaction (DDI) Study of Selpercatinib and Dabigatran in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
A Study of LY3540378 in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Two Different Formulations of LY3209590 in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Lebrikizumab (LY3650150) in Combination With Topical Corticosteroids in Japanese Participants With Moderate-to-Severe Atopic Dermatitis
- Status
- COMPLETED
- Phase
- PHASE3
A Study of LY3549492 in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Abemaciclib (LY2835219) Plus Hormone Therapy in Participants With Early Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE3
Abemaciclib With or Without Atezolizumab for mCRPC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2